Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis

Autor:	V. Gross, Ralph Mueller, Roland Greinwald, Rami Eliakim, A. Lavy, Juris Pokrotnieks, Kęstutis Adamonis, Limas Kupčinskas, Simon Bar-Meir, Zsolt Tulassay, I. Chermesh
Rok vydání:	2007
Předmět:	medicine.medical_specialty medicine.medical_treatment Analgesic Gastroenterology law.invention chemistry.chemical_compound Mesalazine Randomized controlled trial law Internal medicine Medicine Pharmacology (medical) Antipyretic Colitis Hepatology business.industry Enema medicine.disease Ulcerative colitis digestive system diseases Surgery Clinical trial chemistry business medicine.drug
Zdroj:	Alimentary Pharmacology & Therapeutics. 26:1237-1249
ISSN:	1365-2036 0269-2813
Popis:	SUMMARY Background Rectally administered mesalazine (mesalamine; 5-aminosalicylic acid) is the first-line therapy for treatment of distal ulcerative colitis. Recently, a high-volume 5-aminosalicylic acid foam has been shown to be as effective and safe as standard 5-aminosalicylic acid enema.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::604d34f2cba1afa1909717c95299e1ca https://doi.org/10.1111/j.1365-2036.2007.03468.x Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.